# Observational Studies in Action

## Claimed Selections (due 2026-02-10 at noon)

Note: You can read the abstracts for all selections [at this link](https://github.com/THOMASELOVE/500-classes-2026/blob/main/osia/abstracts/README.md).

First Reader | Second Reader | Article 
:------------: | :-------------: | :-----------------------------------------------------------------------------------------------
Jeff Lambe | TBD | Barbuti et al. 2025 <br/> [Comparative effectiveness, safety and persistence of](articles/Barbuti2025_main.pdf) <br/> [ocrelizumab versus natalizumab in multiple sclerosis:](articles/Barbuti2025_main.pdf) <br/> [A real-world, multi-center, propensity score-matched study](articles/Barbuti2025_main.pdf) <br/> *Neuropathics* 22, e00537. <br/> doi: [10.1016/j.neurot.2025.e00537](https://doi.org/10.1016/j.neurot.2025.e00537) <br/> No supplements.
Megan Zelinsky | TBD | Ferreira-Atuesta et al. 2026 <br/> [Timing for Starting Antiseizure Medication Withdrawal](articles/Ferreira-Atuesta2026_main.pdf) <br/> [after Epilepsy Surgery in Adults](articles/Ferreira-Atuesta2026_main.pdf) <br/> *Neurology* 106: e214613 <br/> doi:[10.1212/WNL.0000000000214613](https://doi.org/10.1212/WNL.0000000000214613) <br/> **Supplement** (1 PDF) found on our Shared Drive.
Feriel Presswalla | TBD | Huang YN et al. 2024 <br/> [Long-term safety and efficacy of glucagon-like peptide-1 receptor](articles/HuangYN2024_main.pdf) <br/>  [agonists in individuals with obesity and without type 2 diabetes:](articles/HuangYN2024_main.pdf) <br/> [A global retrospective cohort study](articles/HuangYN2024_main.pdf) <br/> *Diabetes Obes Metab* 26: 5222-5232. <br/> doi: [10.1111/dom.15869](https://doi.org/10.1111/dom.15869) <br/> **Supplement** (1 PDF) found on our Shared Drive.
Lily Zhang | TBD | Hung SK et al. 2023 <br/> [Molecular subtypes of breast cancer predicting clinical benefits](articles/HungSK2023_main.pdf) <br/> [of radiotherapy after breast-conserving surgery:](articles/HungSK2023_main.pdf) <br/> [A propensity-score-matched cohort study](articles/HungSK2023_main.pdf) <br/> *Breast Cancer Research* 25: 149. <br/> doi: [10.1186/s13058-023-01747-9](https://link.springer.com/article/10.1186/s13058-023-01747-9) <br/> No supplements.
Mariam Zayour | TBD | Palzes et al. 2026 <br/> [Glucagon-Like Peptide-1 Receptor Agonists and Alcohol Use:](articles/Palzes2026_main.pdf) <br/> [A Real-Word Observational Study in](articles/Palzes2026_main.pdf) <br/> [a Large, Integrated Health Care System](articles/Palzes2026_main.pdf) <br/> *Biological Psychiatry: Global Open Science* 16:100659 <br/> doi: [10.1016/j.bpsgos.2025.100659](https://doi.org/10.1016/j.bpsgos.2025.100659) <br/> **Supplements** (1 PDF, 1 Excel) found on our Shared Drive.
Fai Albuainain | TBD | Rogerson et al. 2024 <br/> [A matched analysis of the use of high flow nasal cannula](articles/Rogerson2024_main.pdf) <br/> [for pediatric severe acute asthma](articles/Rogerson2024_main.pdf) <br/> *Pediatric Pulmonology* 59: 3457-34766. <br/> doi: [10.1002/ppul.27233](https://doi.org/10.1002/ppul.27233) <br/> **Supplement** (1 PDF) found on our Shared Drive.
Saar Anis | TBD | Siddeeque et al. 2024 <br/> [Neuroprotective effects of GLP-1 receptor agonists](articles/Siddeeque2024_main.pdf) <br/> [in neurodegenerative disorders:](articles/Siddeeque2024_main.pdf) <br/> [A Large-Scale Propensity-Matched cohort study](articles/Siddeeque2024_main.pdf) <br/> *International Immunopharmacology* 143: 113537. <br/> doi:[10.1016/j.intimp.2024.113537](https://doi.org/10.1016/j.intimp.2024.113537) <br/> **Supplement** (1 PDF) found on our Shared Drive.
Kathryn Menta | TBD | Tran et al. 2026 <br/> [Role of Chronic Conditions in Out-of-Pocket Costs for](articles/Tran2026_main.pdf) <br/> [Preventive Care in the US](articles/Tran2026_main.pdf) <br/> *JAMA Network Open* 9(1): e2553157. <br/> doi:[10.1001/jamanetworkopen.2025.53157](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843536) <br/> **Supplements** (1 PDF, 1 Excel) found on our Shared Drive.
Wala'a Alshaia | TBD | Wang et al. 2024 <br/> [Glucagon-Like Peptide 1 Receptor Agonists and](articles/Wang2024_main.pdf) <br/> [13 Obesity-Associated Cancers in](articles/Wang2024_main.pdf) <br/> [Patients With Type 2 Diabetes](articles/Wang2024_main.pdf) <br/> *JAMA Network Open* 7(7): e2421305. <br/> doi:[10.1001/jamanetworkopen.2024.21305](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820833) <br/> **Supplement** (1 PDF) found on our Shared Drive.

